In utero exposure of male rats to the antiandrogen di(n-butyl) phthalate (DBP) leads to decreased anogenital distance (AGD) on postnatal day (PND) 1, increased areolae retention on PND 13, malformations in the male reproductive tract, and histologic testicular lesions including marked seminiferous epithelial degeneration and a low incidence of Leydig cell (LC) adenomas on PND 90. One objective of this study was to determine the incidence and persistence of decreased AGD, increased areolae retention, and LC adenomas in adult rats following in utero DBP exposure. A second objective was to determine whether AGD and areolae retention during the early postnatal period are associated with lesions in the male reproductive tract. Pregnant Crl:CD(SD)BR rats were gavaged with corn oil or DBP at 100 or 500 mg/kg/day, 10 dams per group. Three replicates of rats (n = 30 rats per replicate) were exposed from gestation day 12 to 21 and the male offspring allowed to mature to 6, 12, or 18 months of age. Gross malformations in the male reproductive tract and histologic lesions in the testes were similar to those previously described. However, testicular dysgenesis, a lesion of proliferating LCs and aberrant tubules that has not been previously described in DBP-exposed testes, was diagnosed. The incidence of this lesion was approximately 20% unilateral and 7-18% bilateral in the high-dose group and was similar among all ages examined, implicating a developmental alteration rather than an age-related change. AGD and areolae retention were found to be permanent changes following in utero exposure to 500 mg/kg/day of DBP. Decreased AGD was a sensitive predictor of lesions in the male reproductive tract, relatively small changes in AGD were associated with a significant incidence of male reproductive malformations. In utero DBP exposure induced proliferative developmental lesions, some of which would have been diagnosed as LC adenomas by the morphological criteria set forth by the Society of Toxicologic Pathology. However, these lesions were dissimilar to traditional LC adenomas as the LCs were poorly differentiated and the lesions contained aberrant seminiferous tubules. While the morphology and incidence of this DBP-induced testicular developmental lesion has been fully characterized by this study, the detailed pathogenesis warrants further investigation.
INTRODUCTION
Di(n-butyl) phthalate (DBP) acts as an antiandrogen when male rats are exposed in utero by decreasing fetal testicular testosterone (T) production (Shultz et al., 2001; Mylchreest et al., 2002; Lambright et al., 2003) . Due to DBP use in soft plastics and personal care products such as shampoo, deodorant, and hair spray, a potential for human exposure exists (International Programme on Chemical Safety, 1997). When male rats were exposed to DBP at 500 mg/kg/day during the latter half of gestation and examined on GD 17 to 21, they exhibited a characteristic suite of testicular lesions including the formation of large aggregates of Leydig cells (LC), increased numbers of gonocytes within seminiferous cords, and multinucleated gonocytes (Barlow and Foster, 2003) . Nearly 100% of males exposed to DBP during the last 10 days of gestation had at least 2 of these 3 morphologic characteristics. During the early postnatal period, these lesions resolved, although the adult testis developed seminiferous epithelial degeneration, which became more severe following sexual maturity (Barlow and Foster, 2003) . Studies in our labora-tory and others have demonstrated that male rats exposed in utero to DBP exhibit malformations of the epididymis, seminal vesicles, prostate, and penis following in utero exposure to DBP (Gray et al., 1999; Mylchreest et al., 1999 Mylchreest et al., , 2000 .
AGD and areolae retention are sexually dimorphic end points that are androgen-dependent in the male rat. T is locally converted to dihydrotestosterone (DHT), causing lengthening of the perineum, the male AGD being approximately 2 to 3 times longer than the female AGD on postnatal day (PND) 1 (Neumann et al., 1970; Gray et al., 1999; McIntyre et al., 2001) Antiandrogens may cause decreases in AGD through a variety of mechanisms, including disruption of androgen synthesis or signaling (Neumann et al., 1970; Gray et al., 1999) . Permanent decreases in AGD have been found for several antiandrogens, including the androgen receptor antagonists flutamide and linuron (McIntyre et al., 2001 (McIntyre et al., , 2002 . In addition to being permanently decreased by flutamide, AGD on PND 1 was predictive of subsequent lesions in DHT-dependent tissues of adult offspring, while flutamideinduced changes in AGD were not sensitive indicators of altered T-mediated development (McIntyre et al., 2001) . Although AGD was permanently decreased following in utero exposure to linuron, the decrease was not associated with subsequent morphologic changes in the adult male reproductive tract (McIntyre et al., 2002) . Male offspring exposed TOXICOLOGIC PATHOLOGY in utero to the organophosphate insecticide fenitrothion, another androgen receptor antagonist, exhibited a slight decrease in AGD on PND 1; however, this change was transient, and was not observed in adults (Turner et al., 2002) . Gestational DBP exposure has been shown to decrease AGD on PND 1 (Mylchreest et al., 1999 (Mylchreest et al., , 2000 Barlow and Foster, 2003) . It was of interest to determine whether the decreased AGD following gestational exposure to DBP, an androgen biosynthesis inhibitor, was permanent and whether the reduction was associated with morphological alterations of the male reproductive tract in the adult offspring (Gray et al., 1999; Mylchreest et al., 1999 Mylchreest et al., , 2000 .
DHT causes apoptotic regression of the nipple anlagen in male rats (Neumann et al., 1970; Imperato-McGinley et al., 1986) . Therefore alteration of androgen levels in male fetuses or blockade of the androgen receptor may lead to increased retention of areolae that would otherwise have undergone DHTdependent regression. Similar to antiandrogen-mediated decreases in AGD, linuron, DBP, flutamide, and fenitrothion induced areolae retention on PND 13 (Gray et al., 1999; Mylchreest et al., 1999 Mylchreest et al., , 2000 McIntyre et al., 2001 McIntyre et al., , 2002 Turner et al., 2002) . Permanent nipples have been observed during adulthood for linuron, flutamide, and DBP, whereas areolae were a transient effect for fenitrothion. An association between the number of DBP-induced areolae on PND 13 and subsequent morphologic lesions in the adult male reproductive tract has not been established.
In 2 separate studies by Mylchreest et al. (1999 Mylchreest et al. ( , 2000 , in utero DBP exposure led to a low incidence of LC adenomas in male offspring at 3 months of age. This was an unprecedented finding since the rats in the Mylchreest studies were only exposed to DBP in utero and were 90 days of age at necropsy. The combined incidence of LC adenomas in the 2 Mylchreest studies was ∼3%, which is within the range of incidence (1.4-13.3%) for control rats from 9 separate 2-year carcinogenicity studies using Sprague-Dawley rats (McMartin et al., 1992) . The cumulative incidence in these studies was 6.5%, while Charles River Laboratories in Raleigh, NC (the supplier of rats for this and the Mylchreest studies) reported an incidence in old rats of approximately 5% (Lang, 1992) .
Endocrine-active compounds have been shown to induce neoplasia following prenatal or early postnatal exposure. Diethylstilbestrol (DES), a synthetic estrogen, is the most widely studied endocrine-active agent that has been shown to lead to formation of uterine and vaginal neoplasia in offspring of female humans and rodents exposed to DES during gestation (Herbst et al., 1972; Newbold, 1995; Newbold et al., 2002) . DES has also been shown to cause an increased incidence of testicular neoplasia in male mice exposed over a short gestational window (Newbold et al., 2000) . The phytoestrogen genistein, which is found in high levels in many soybased formulas, results in a potentially high postnatal exposure in human infants. When rats were treated with equivalent estrogenic doses on PND 1 to 5 and examined at 18 months of age, genistein induced a rate of uterine adenocarcinoma of approximately 35%, which was similar to DES when exposed on the same days (Newbold et al., 2001) . Taken together, these compounds illustrate the unique sensitivity of the developing reproductive tract to perturbation by endocrine-active agents.
The potential for DBP to act as a transplacental carcinogen was investigated in the present study using a study design that involved exposure of male rats only during the fetal period (GD 12 to 21) with examination of the reproductive tracts of adult male offspring at 6, 12, and 18 months of age. Comparison with the Mylchreest studies (1999 Mylchreest studies ( , 2000 was made to determine whether the incidence of LC adenomas following in utero DBP exposure increased over time or whether the incidence was the same as that seen in 90-day-old rats regardless of the age of the animal at the time of examination. In addition, rats in the 6-month group were utilized to determine whether the changes in AGD and areolae retention observed on PND 1 and 13 were permanent. Males in this cohort of rats were uniquely identified on PND 1, and AGD and areolae retention during the early postnatal period were compared to these parameters collected at necropsy on PND 180. Since rats were uniquely identified, association of decreased AGD and increased areolae retention with male reproductive tract lesions was also investigated.
METHODS

Animals
This study was conducted in concordance with Federal guidelines (National Research Council, 1996) for the care and use of laboratory animals and was approved by the Institutional Animal Care and Use Committee at the CIIT Centers for Health Research. The CIIT animal care facility is accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care. Ninety pregnant CRL:CD(SD)BR rats were time-mated at Charles River Breeding Laboratories (Raleigh, NC) and shipped to CIIT on gestation day (GD) 0, the day sperm was detected in the vaginal smear. Dams were assigned to replicates and treatment groups by body weight randomization using the Provantis (Instem LSS, Stone, UK) data acquisition system. Ten dams were assigned to each treatment group, thirty dams per replicate. Treatment groups included a control (0 mg/kg/day DBP), low-dose (100 mg/kg/day DBP), and a high-dose (500 mg/kg/day DBP). The dose levels of DBP were chosen based on studies by Mylchreest et al. (1999 Mylchreest et al. ( , 2000 indicating that LC adenomas developed when male pups were exposed to 500 mg/kg/day on GD 12 to 21 and on the statistically significant retention of areolae at 100 mg/kg/day. When more than 30 dams for each replicate were received from the breeding facility, the additional dams were assigned to the high-dose group. Dams were identified by ear tags and cage cards, and male pups were identified by subcutaneous transponders placed on PND 21 and cage cards. Dams were housed individually in polycarbonate cages with Alpha-dri cellulose bedding (Shepherd Specialty Papers, Kalamazoo, MI). Males were group-housed by litter following weaning, 3 per cage, until size necessitated housing 2 per cage and ultimately 1 per cage for the duration of the study. Rodent diet NIH-07 (Zeigler Brothers, Gardener, PA) and reverseosmosis water were provided ad libitum. Rats were kept in a humidity-and temperature-controlled, HEPA-filtered, mass air-displacement room. The room was maintained on a 12-hr light-dark cycle at approximately 18 • -26 • C with a relative humidity of approximately 30-70%. DBP in corn oil at 100 and 500 mg/kg/day (Aldrich Chemical Company, Milwaukee, WI). Dam body weights were recorded on GD 9 and daily during the dosing period. Male pups were weaned on PND 21, while the dams and female pups were euthanized by CO 2 asphyxiation and aortic transection without examination. Male pups were necropsied at 6, 12, or 18 months of age.
Male Necropsies and Other Antiandrogenic End Points
The males in the 6-month replicate were utilized for additional measurements, including AGD and areolae or nipple retention. A single investigator, blinded to treatment, performed all measurements. Male pups in this replicate were uniquely identified on PND 1 using footpad tattoos, which corresponded to the transponders placed on PND 21, to allow for data collection and comparison of data collected from individual rats over their lifetime. AGD, the distance from the anus to the genital papilla, was measured on PND 1 using a dissecting microscope with an eyepiece reticle. AGD was measured following euthanasia at necropsy (PND 180) with a manual caliper. Areolae were counted on PND 13. No discrimination between areolae with or without a nipple bud was made. The ventral surface of the thorax and abdomen of all rats necropsied on PND 180 was shaved for the counting of nipples. All morphologic structures in appropriate areas, from small blemishes to florid nipples, were counted.
Necropsies were performed on PND 180, 370, or 540. Males were anesthetized with isoflurane (Fort Dodge, Overland Park) by nose cone exposure and euthanized by cardiac puncture. Necropsies included full evaluation of the external genitalia and the internal reproductive organs by a single veterinary pathologist. Epididymides and all organs with gross lesions were fixed in 10% neutral-buffered formalin. Testes were fixed in modified Davidson's fixative for 48 hr and then transferred to 10% neutral-buffered formalin (Lanning et al., 2002; Latendresse et al., 2002) . All moribund rats and rats found dead prior to their scheduled sacrifice were necropsied with collection of protocol-specified tissues and all macroscopic lesions. The entire testes were sampled in 4 crosssections, with all sections being examined microscopically. The testes, epididymides, and all tissues with macroscopic findings from unscheduled deaths were processed, embedded in paraffin, sectioned at 5 µm, and stained with hematoxylin and eosin. Tissues from moribund or dead rats were examined histologically to confirm the cause of death. Data from testes or epididymides of dead or moribund rats were not included in the data from the rats necropsied at the scheduled sacrifices.
Statistical Analyses
Statistical analyses were conducted using JMP (version 4.0.0, SAS Institute, Cary, NC). The litter was the experimental unit for all the age groups, and data were analyzed nested by dam to yield litter means. Significance for all treatment effects was p < 0.05. Pathology data were analyzed using a Chi Square test followed by the Fisher's Exact Test. Quantitative pup data were analyzed by a repeated measure ANOVA (nested design) or ANCOVA with the covariates listed in the figure legends. Contrasts of least-square means were used to test for significance of treatment effects. Results are expressed as the least squares means ± standard error of the mean. Linear regression was used to determine the association of AGD measurements in individual animals on PND 1 to AGD on PND 180 for the same individually identified animals. To determine the association of decreased AGD on PND 1 to lesions within the male reproductive tract, logistic regression was employed. Following logistic regression, the receiver operator characteristic (ROC) and inverse prediction functions were performed. The ROC values approaching 1 were predictive of an association between decreased AGD and lesions in the reproductive tract, while values nearing 0.5 were not predictive (Hanley and McNeil, 1982) . The inverse prediction function determines the AGD at which 50 and 10% of the rats will have a lesion in a particular tissue of the reproductive tract.
RESULTS
Gross Pathology
Malformations observed in the male reproductive tracts of mature rats were similar to those previously described in young adult males and did not vary significantly by age (Gray et al., 1999; Mylchreest et al., 1999 Mylchreest et al., , 2000 Barlow and Foster, 2003) . Lesions in the testes included atrophy with flaccid capsules, occasional enlargement with abundant amounts of interstitial fluid, and rarely absence of the testis. These alterations occurred unilaterally and bilaterally, though the bilateral manifestation predominated for the atrophied and enlarged testes (Table 1 ). Enlarged testes were only observed in the 500 mg/kg/day dose group and were often accompanied by malformed epididymides. Epididymal lesions occurred predominantly in the high-dose group (Table 1) . While small numbers of epididymal changes were present in the control and low-dose groups, these lesions were hypoplastic epididymides with all portions of the organ present. In the high-dose group, most epididymides were malformed with absence of various portions or absence of the entire epididymis.
The morphologic alteration observed in the vasa deferentia was absence of the tissue. Absent vasa deferentia were frequently associated with malformed or absent epididymides and occurred unilaterally and bilaterally, although the numbers tended to be more evenly distributed (Table 1 ). The other reproductive tissue derived from the Wolffian ducts, the seminal vesicles, also developed DBP-induced lesions, which occurred only in the 500 mg/kg/day dose group (Table 1) . Seminal vesicles were small or malformed with decreased intraluminal secretions or were completely absent. On PND 540, age-induced lesions of the seminal vesicles were observed in the control and low-dose DBP rats (Table 1) . The alteration noted in these rats, a slight decrease in seminal vesicle size, was markedly different from those in the high-dose DBP group, which had marked decreases in seminal vesicle size with malformed or absent lobes.
Changes noted in DHT-dependent tissues were also most frequently observed in the high-dose group (Table 1) . Prostates were frequently small to absent with both the ventral and dorsolateral lobes affected. Small numbers of lesions were noted in control and low-dose rats on PND 370 with markedly increased numbers seen in these groups on PND 540 (Table 1) . However, prostates in these rats were only slightly decreased in size. Hypospadias, a malformation TOXICOLOGIC PATHOLOGY of the penis with ectopic location of the urethral opening on the ventral surface, was observed only in the high-dose group (Table 1) . Pituitary gland masses were present in all dose groups of the PND 370 and 540 replicates, but were not observed in the PND 180 rats. Statistically significant differences in the occurrence of pituitary adenomas between control and dosed rats were not observed.
Histopathology
Proliferative LC lesions were observed at all time points examined (Table 2) . Classical LC adenomas, masses of welldifferentiated LCs larger than the diameter of 3 seminiferous tubules ( Figure 1B ), were only observed in small numbers on PND 540 in the control and low-dose groups except for a single tumor in a control animal on PND 370. LC hyperplasias, areas of well-differentiated LCs smaller than 3 seminiferous tubules, were noted in the high-dose group on PND 180, in low-and high-dose groups on PND 370, and in all 3 doses on PND 540. The incidence of LC hyperplasia was not significantly different for any of the dose groups.
Testicular dysgenesis, defined as aberrant seminiferous tubules associated with proliferative LCs, was seen in the high-dose group at all 3 time points, except for a single an-FIGURE 1.-Photomicrographs of testes from rats exposed to vehicle or DBP, 100 or 500 mg/kg/day, on gestation days 12 to 21. (A) Control testis on postnatal day (PND) 540. H&E. ×50. (B) DBP-exposed testis (100 mg/kg/day) on PND 540. A large Leydig cell (LC) adenoma ( * ) is present with multiple smaller areas of LC hyperplasia (arrowheads). There is no seminiferous epithelial degeneration in this testis. H&E. ×50. (C) DBP-exposed testis (500 mg/kg/day) on PND 370. Area of testicular dysgenesis including convoluted, immature seminiferous tubules and large numbers of LCs. The surrounding tubules have marked seminiferous epithelial degeneration, and the interstitium is markedly expanded by interstitial fluid. H&E. ×50. (D) DBP-exposed testis (500 mg/kg/day) on PND 540. Higher magnification of dysgenetic area of the testis with immature appearing and dilated tubules and numerous spindloid LCs. H&E. ×125. (E) DBP-exposed testis (500 mg/kg/day) on PND 540. Area of testicular dysgenesis with markedly dilated tubules and relatively few LCs. H&E. ×50. (F) DBP-exposed testis (500 mg/kg/day) on PND 370. Focal area of LCs located in a similar area to other dysgenetic lesions but containing no aberrant tubules. The interstitium of this testis is markedly expanded by interstitial fluid. H&E. ×125. (G) Control testis on PND 540. The rete testis is the flattened duct near the capsule of the testis (arrowheads). A single tubule (tubuli recti) (arrow) that connects the seminiferous tubules and rete testis is present. H&E. ×125. (H) DBP-exposed testis (500 mg/kg/day) on PND 540. The area of the rete testis is markedly expanded by fibrous connective tissue ( * ). Sertoli cells with few germ cells line the surrounding seminiferous tubules. H&E. ×125.
imal in the control group on PND 370. These dysgenetic areas varied markedly in morphology but were always located in the same region of the testis, the central area of sections containing the rete testis. They were most often observed in a single section but were occasionally seen in the same area of multiple sections, indicating a single lesion that extended through the testis. Size of the dysgenetic areas varied, with some areas greater than the diameter of three seminiferous tubules. Testicular dysgenesis occurred with approximately the same incidence across all age groups and was much more prevalent as a unilateral finding (Table 2) . Dysgenetic areas contained variable numbers of seminiferous tubules and LCs. The tubules were often convoluted and lined by immature-appearing Sertoli cells (Figures 1C and D) . In many lesions the tubules had small lumina, while in some the tubules were mildly dilated ( Figure 1D) ; and in others they were markedly dilated with only flattened Sertoli cells ( Figure 1E ). Dilation of the tubules supports incomplete anastomosis with the rete testis and lack of tubular fluid drainage. LCs within dysgenetic areas varied in number and differentiation and surrounded the immature tubules, often forming mass lesions ( Figures 1C and 1D) . These LCs were spindloid with decreased amounts of cytoplasm. In other TOXICOLOGIC PATHOLOGY Unilateral LC adenoma a 0 (0) b 0 (0) 0 (0) 2 (10) 0 (0) 0 (0) 2 (11) 2 (10) 0 (03) LC hyperplasia c 0 (0) 0 (0) 2 (9) 0 (0) 2 (11) 4 (27) 7 (11) 4 (10) 3 (13) areas, especially around the markedly dilated tubules, very few LCs were present ( Figure 1E ). In several testes, there were proliferative LCs around small blood vessels that were not associated with seminiferous tubules ( Figure 1F ). While these areas did not appear to be dysgenetic (i.e., they did not contain seminiferous tubules), they were located in the same central region as the other dysgenetic lesions. The incidence of seminiferous epithelial degeneration was similar to that previously reported in adult rats exposed in utero to 500 mg/kg/day of DBP (Table 2) , (Barlow and Foster, 2003) . The degeneration in most testes affected nearly 100% of the tubules with complete lose of germ cells, leaving only Sertoli cells. Many of the testes contained tubules or areas of granulomatous inflammation with inflammation frequently surrounding areas of mineralization. The rete testis was often expanded by the presence of sperm and surrounded by granulomatous inflammation. The inflammatory lesion of the rete was most prevalent on PND 180 and 370. In the PND 370 group, inflammation often appeared to be resolving with increased amounts of fibrous connective tissue surrounding the rete. Rete fibrosis with minimal to mild granulomatous inflammation was the predominant lesion on PND 540 ( Figure 1H ).
Anogenital Distance
The AGD of uniquely identified male pups was measured on PND 1 and 180. Male pups in the 500 mg/kg/day group exhibited statistically significantly decreases of 14 and 10%, respectively (Figure 2 ). Linear regression on the AGD of individual rats on PND 1 versus the same animal's AGD on PND 180 was performed with a coefficient of determination (r 2 ) of 0.80, indicating that a decrease in AGD observed on PND 1 was strongly associated with a decrease in AGD on PND 180 (Figure 3 ). While the litter means for AGD of rats in the 100 mg/kg/day group were not significantly different from control (Figure 2 ), analysis of individual males did show separation from controls by a subset of rats in this dose group (Figure 3) .
The ability of decreased AGD on PND 1 to predict male reproductive tract alterations was tested using logistic regression. All the values for reproductive tissues examined in this study were significant, including any changes in the reproductive tract, regardless of the organ. Decreased AGD on PND 1 was a strong predictor of a lesion in each particular tissue, as indicated by the ROC values near 1.0 ( Table 3) . The M 50 and M 10 values (AGD in mm), and their corresponding confidence intervals, are the AGDs at which 50 and 10% of the rats would have a lesion, gross or histologic, in a particular tissue. While some tissues have a ROC value close to 1.0 (e.g., penises ROC = 0.96) indicating that decreased AGD is strongly predictive of a lesion in this tissue, a marked reduction in AGD may be needed to achieve either 50 or 10% incidence (Table 3) . For other organs, AGD is slightly less predictive (e.g., testes ROC = 0.9), but only a slight reduction in AGD is necessary to achieve the same incidences. FIGURE 2.-Mean anogenital distance (AGD) from control and DBP-exposed male pups on postnatal days 1 and 180. Dams were exposed to vehicle or DBP, 100 and 500 mg/kg/day, on gestation days 12 to 21. Values are nested litter means ± SEM with body weight as a covariate for AGD. *Significantly different from control ( p < 0.05). Vol. 32, No. 1, 2004 CHRONIC LESIONS OF IN UTERO DBP EXPOSURE 85 FIGURE 3 .-Individual anogenital distances (AGD) on postnatal day (PND) 1 versus the same animal's AGD on PND 180. Male pups were exposed to DBP at 100 or 500 mg/kg/day on gestation days 12 to 21. Linear regression of the fit line yields a coefficient of determination of 0.80. The AGD for the 500 mg/kg/day dose group was significantly decreased from controls on PND 1 and 180. While the 100 mg/kg/day group was not significantly different on a litter mean basis, a subset of the rats did have a slightly lower AGD on both time points.
Areolae and Nipple Retention
Areolae and nipples were counted on uniquely identified pups on PND 13 and 180. No distinction between areolae with or without a nipple bud on PND 13 was made. Nipples on PND 180 ranged from small, slightly raised areas on the skin in the appropriate position of a nipple to fully developed nipples. Areolae retention was significantly increased in both the low-and high-dose DBP groups relative to control (Figure 4) . On PND 180, retained nipples were significantly increased above control in the 500 mg/kg/day dose group (Figure 4) . Though significantly increased, there were fewer nipples per animal in the 500 mg/kg/day group on PND 180 than on PND 13, ∼4.5 nipples versus ∼10 areolae.
To determine whether areolae detected on PND 13 in the DBP-exposed rats were associated with gross or histologic lesions in the male reproductive tract, the number of areolae were plotted against the proportion of the total number of rats responding ( Figure 5 ). The number of areolae were segregated into five blocks: 0, 1-3, 4-6, 7-9, and 10-12 areolae. A minimal response was seen in the testes in both the 0 and 1-3 areolae group ( Figure 5 ). Approximately 7-12% of the rats with morphologic alterations in all tissues besides the a Receiver operator characteristic (ROC) describes that ability of anogenital distance (AGD) on PND 1 to predict lesions in the tissues of the male reproductive tract. Gross and histologic lesions were included in the analyses. 1.0 is highly predictive while 0.5 is not predictive.
b Inverse prediction value at which 50 and 10% of the animals will exhibit lesions (gross or histologic) in a given tissue. c 95% confidence limits of the inverse prediction value. FIGURE 4.-Areolae and nipple retention from control and DBP-exposed male pups on postnatal days 13 and 180. Dams were exposed to vehicle or DBP, 100 and 500 mg/kg/day, on gestation days 12 to 21. Values are nested litter means ± SEM. *Significantly different from control ( p < 0.05).
penis were in the 4-6 areolae response group. All of the tissues behaved similarly in the 7-9 and 10-12 areolae groups with approximately 20% of the rats in the former and 65-75% of the lesioned rats in the latter group. All the responders for hypospadias were in the 10-12 areolae group. Approximately 70% of the DBP-exposed rats that did not exhibit a lesion had nipples.
Survival
Adverse effects on survival were observed only in the 500 mg/kg/day dose group of the 540-day replicate (Table 1, Figure 6 ). Minimal to no rats were lost in all dose groups for the 180-day and the 370-day replicates. In the control and 100 mg/kg/day dose group of the 540-replicate, no rats died prior to PND 350, which is similar to that seen for the other 2 replicates. However, significant early deaths of rats in the high-dose group were seen. The rate of these losses eventually declined and the high dose survival from 350 to 540 days was similar to the control and low-dose groups for that replicate ( Figure 6) .
Rats in the high-dose group that died early (i.e., prior to PND 350) exhibited urinary tract obstructions, often associated with cysto-and nephrolithiasis ( Table 4 ). The urinary bladders of these rats were often markedly enlarged and filled with red urine ( Figure 7A) . Dilated ureters and hydronephrosis were also observed. The point of obstruction TOXICOLOGIC PATHOLOGY FIGURE 5.-Areolae retention on postnatal day 13 versus the percentage of rats with gross or histologic lesions in a particular tissue. Male pups were exposed to exposed to DBP at 100 or 500 mg/kg/day on gestation days 12 to 21. The number of areolae were segregated into blocks, 0, 1-3, 4-6, 7-9, and 10-12 areolae. Rats with lesions in each tissue were plotted as a response against each areolae block. The response rate was the number of lesioned rats in that group divided by the total number of lesioned rats, totaling 100% in all 5 blocks. The same percentage response was calculated and graphed for the DBP-exposed rats with no lesions. was frequently at the cranial flexure of the urethra as it exited the pelvic canal. This area frequently contained uroliths or large, gritty, proteinaceous plugs ( Figure 7B ). Urinary bladders were also completely filled and dilated by large uroliths (Figure 7C ). When the urinary bladders were opened, they contained variably sized uroliths that often had rough surfaces ( Figure 7D ). The stones from a single animal were cultured and analyzed. Proteus mirabilis was cultured from the urine of this animal. The stones were found to be magnesium ammonium phosphate (struvite). Since the clinical syndrome was similar for all rats and the uroliths had similar appearances, analyses on the stones or urine of other rats were not performed. In addition to hydronephrosis, kidneys with ascending pyelonephritis were also observed ( Figure 7E) .
Following 350 days, common causes of death or morbidity were seen in all the dose groups (Table 4 ). These findings included pituitary adenomas, chronic interstitial nephritis, and small numbers of other neoplasms. Pituitary adenomas were large masses that extended from the floor of the brain case, compressing the brain ( Figure 7F ). If a cause of death was not determined, the animals were not included in Table 4 .
DISCUSSION
The main objective of this study was to further investigate the potential transplacental carcinogenicity of DBP, specifically the induction of LC adenomas in male Sprague-Dawley rats exposed to DBP on GD 12 to 21. Rats were examined at 6, 12, or 18 months of age, with no observed increase in clas-sical LC adenomas, histologically defined as nodular proliferations of generally well-differentiated LCs (Mitsumori and Elwell 1988; Boorman et al., 1990; Qureshi et al., 1991) . LC adenomas frequently encompass seminiferous tubules and compress tubules adjacent to the mass. The Society of Toxicologic Pathology (STP) recommends the diagnosis of adenoma for proliferations of LCs greater than three seminiferous tubules in diameter, while those less than that are areas classified as hyperplasia (McConnell et al., 1992) . Only small numbers of classically defined hyperplasia and adenomas were observed in this study with no differences in incidence among control, low, and high doses of DBP.
While no differences were observed in LC hyperplasia or adenomas, proliferative areas, defined as testicular dysgenesis, were observed in the high-dose group. Testicular dysgenesis was always found in a similar area of the testis, the central region of sections containing the rete. These lesions varied in size and, by the STP criteria, would have been diagnosed as areas of LC hyperplasia and adenomas. However, the morphology of the dysgenetic areas differed from traditional LC proliferations. The dysgenetic areas were observed in the high-dose group only, save for one lesion in a control animal, and the incidence was similar among the 6, 12, and 18-month replicates. This implies that testicular dysgenesis did not appear over time; rather, formed in utero while the differentiating testes were being exposed to DBP and continued to develop as rats aged. While occasionally found in both testes, testicular dysgenesis was predominantly a unilateral Vol. 32, No. 1, 2004 CHRONIC LESIONS OF IN UTERO DBP EXPOSURE 87 FIGURE 6 .-Survival curves for male pups exposed to DBP at 0, 100, or 500 mg/kg/day on gestation days 12 to 21. Losses of rats were similar for all dose groups of the 180-and 370-day replicates. No differences in survival for the control and 100 mg/kg/day dose groups in the 540-day replicate, 77 and 83% survival, respectively, were noted. However, a significant difference in survival for the high-dose group of this replicate, approximately 57%, was observed. lesion. The lesions from Mylchreest et al. (1999 Mylchreest et al. ( , 2000 were reviewed and were found to be similar to the areas diagnosed as testicular dysgenesis in the current study. The original diagnosis of LC adenoma by Mylchreest et al. was not incorrect since the size and the morphology of the lesions fit the criteria for LC adenomas set by the STP. The areas of testicular dysgenesis observed in this study could have also been diagnosed as LC adenomas. However, the morphology, consistent location, and similar incidence between ages led to the diagnosis of testicular dysgenesis. The overall incidence of testicular dysgenesis in the two Mylchreest studies was only 3% compared with approximately 20% incidence in this study. Knowing that only a small number of LC adenomas were expected, cross-sections of the entire testis, four sections per testis, were examined, which increased the ability to find histologic lesions and was a potential explanation for the difference in incidence levels among the three studies. The pathogenesis of testicular dysgenesis is not completely understood.
Similar to flutamide and linuron, AGD was permanently decreased following in utero exposure to DBP (McIntyre et al., 2001 . The DBP-induced decrease was significant at the high dose on both PND 1 and 180. While male offspring in the 100 mg/kg/day dose group exhibited a decrease in AGD on PND 1 and 180, this did not achieve statistical significance. The rats in this dose group with slightly decreased AGD on PND 1 were the same rats with decreased AGD on PND 180, emphasized by the subset of rats separated from the control rats and other low-dose rats in Figure 3 . In addition to being a permanent change induced by in utero exposure to 500 mg/kg/day of DBP, the decreased AGD was also predictive of gross or histologic changes in the male reproductive tract as illustrated by the ROC values. While AGD seemed to be more predictive of lesions in tissues such as the seminal vesicles and prostate (ROC = 0.97) versus the testes and epididymides (ROC = 0.90 and 0.92), a greater magnitude of change in AGD was required to observe either a 50 or 10% incidence of lesions in the prostate or seminal vesicles. In the case of the seminal vesicles or prostate, a decrease in AGD of approximately 12% was necessary to observe a 50% incidence of rats with an alteration in those organs, while only an 8% decrease was necessary to see the same incidence in TOXICOLOGIC PATHOLOGY the testes. To note a 10% incidence of a lesion in the testes or epididymides, a decrease in AGD of only 2-2.5% was necessary. Though the decreased AGD at 100 mg/kg/day was not statistically significant, this decrease may be biologically significant since this magnitude of change was all that was necessary to predict lesions in the testes and epididymides. While areolae observed on PND 13/14 have been shown to be permanent following in utero DBP exposure, whether nipples induced by exposure to 100 mg/kg/day, a relatively low-dose of DBP, would be permanent was of interest (Gray et al., 1999) . Areolae were significantly increased at the low dose on PND 13 but were not elevated on PND 180, indicating this to be a transient effect at 100 mg/kg/day. Additionally, in the 500 mg/kg/day dose group, approximately 10 areolae per animal were counted on PND 13 whereas only 4 nipples per animal were counted on PND 180. Therefore, many of the areolae counted on PND 13 did not persist as nipples, even at the high dose. While decreased AGD on PND 1 was predictive of lesions in the male reproductive tact, increased areolae retention on PND 13 does not appear to behave in the same fashion; in fact, a full complement of areolae (i.e., greater than 9 areolae) were necessary before markedly increased numbers of malformations were present. Moreover, approximately 70% of the DBP-exposed rats that did not exhibit a lesion had nipples. While nipples were permanent following in utero linuron exposure, which is similar to DBP, they were not predictive of reproductive tract lesions in adult male offspring (McIntyre et al., 2002) .
Prior to this study, DBP had not been shown to cause decreased survival of the male offspring at doses up to 500 mg/kg/day (Gray et al., 1999; Mylchreest et al., 1999 Mylchreest et al., , 2000 . Decreased survival was seen in 1 group in this study, the high-dose group of the 18-month replicate. Urinary obstruction with ascending pyelonephritis was the common finding in most rats that died prior to PND 350. The definitive cause of the urolithiasis and urinary obstruction in these rats was not identified. These rats did have malformations of their genitourinary tracts that may have predisposed them to urinary tract infections, urolith formation, and urinary obstruction. Proteus mirabilis is a common crystal-forming bacteria often cultured from the urinary tract of rats with uroliths (Larsson et al., 1989; Takeuchi et al., 1991) . Proteus is a urease producer, which leads to breakdown of urea to ammonium ions and the formation of alkaline urine, a prerequisite for struvite crystal formation (Larsson et al., 1989) . Additionally, in a controlled study of multiple urease-producing bacteria, Proteus mirabilis produced the most severe kidney lesions (Larsson et al., 1989) . All the rats were housed in Vol. 32, No. 1, 2004 CHRONIC LESIONS OF IN UTERO DBP EXPOSURE 89 FIGURE 7.-Gross lesions from rats exposed to 500 mg/kg/day DBP on gestation days 12 to 21. All lesions were from rats found moribund or dead prior to their scheduled necropsy times. (A) The urinary bladder ( * ) was markedly dilated and filled with dark red fluid. The ureters were bilaterally dilated (arrows). (B) The obstruction of the animal in Figure 7A occurred at the flexure of the urethra as it exited the pelvic canal. A large, gritty, proteinaceous plug was found at the site (arrow). Once removed, the urethra cranial and caudal to the plug was patent. (C) The urinary bladder was markedly dilated and filled with large uroliths (arrow). (D) Another example of a urinary bladder filled with variably sized, rough stones. (E) Kidney from an animal with urinary obstruction. Multiple, coalescing, firm, raised inflammatory nodules throughout the parenchyma were present. (F) Caudal view of a large pituitary gland adenoma that had caused compression of the overlying brain. the same room with the same bedding, food, and water. Rats in the high-dose group had similar reproductive tract lesions regardless of replicate, so it is unclear why 1 particular group of the 18-month replicate was affected.
In summary, the current study demonstrated that in utero exposure to DBP did not increase the incidence of classically defined LC adenomas. Rather, a lesion not previously described in the testis that was similar in incidence regardless of the age examined was observed, implicating formation during development of the testes. The pathogenesis of testicular dysgenesis is not completely understood, but, given the morphology and similar location in the testes, there is possibly a group of cells or a structural area in the fetal testis that is particularly susceptible to DBP exposure. This conclusion is supported by the presence of abnormal areas in DBP-exposed testes with no other lesions. Further studies are necessary to elucidate the pathogenesis and significance of this lesion. In addition, alterations in AGD and areolae retention were permanent at 500 mg/kg/day and decreased AGD was predictive of DBP-induced male reproductive tract lesions. This study, which more fully evaluates the reproductive developmental toxicity of DBP in the male rat, provides
